GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BioLife Solutions Inc (FRA:BJX1) » Definitions » Inventories, Finished Goods

BioLife Solutions (FRA:BJX1) Inventories, Finished Goods : €12.57 Mil (As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is BioLife Solutions Inventories, Finished Goods?

BioLife Solutions's quarterly finished goods declined from Jun. 2024 (€12.14 Mil) to Sep. 2024 (€11.54 Mil) but then increased from Sep. 2024 (€11.54 Mil) to Dec. 2024 (€12.57 Mil).

BioLife Solutions's annual finished goods increased from Dec. 2022 (€7.81 Mil) to Dec. 2023 (€8.27 Mil) and increased from Dec. 2023 (€8.27 Mil) to Dec. 2024 (€12.57 Mil).


BioLife Solutions Inventories, Finished Goods Historical Data

The historical data trend for BioLife Solutions's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioLife Solutions Inventories, Finished Goods Chart

BioLife Solutions Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.54 5.38 7.81 8.27 12.57

BioLife Solutions Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.27 11.36 12.14 11.54 12.57

BioLife Solutions Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.


BioLife Solutions Business Description

Traded in Other Exchanges
Address
3303 Monte Villa Parkway, Suite 310, Bothell, WA, USA, 98021
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.

BioLife Solutions Headlines

No Headlines